|
2018 June |
Desmetilació genòmica com a biomarcador de predisposició a càncers múltiples |
Navarro Jiménez, Maria
|
|
|
2016 August 31 |
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients |
Cubiella, Joaquín
; Vega, Pablo
; Salve, María
; Díaz Ondina, Marta
; Alves, Maria Teresa
; Quintero, Enrique
; Álvarez Sánchez, Victoria
; Fernández Bañares, Fernándo
; Boadas, Jaume
; Campo, Rafel
; Bujanda, Luis
; Clofent, Joan
; Ferrandez, Ángel
; Torrealba, Leyanira
; Piñol Sánchez, Virgínia
; Rodríguez Alcalde, Daniel
; Hernández, Vicent
; Fernández Seara, Javier
|
|
|
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients |
Cubiella, Joaquín
; Vega, Pablo
; Salve, María
; Díaz Ondina, Marta
; Alves, Maria Teresa
; Quintero, Enrique
; Álvarez Sánchez, Victoria
; Fernández Bañares, Fernándo
; Boadas, Jaume
; Campo, Rafel
; Bujanda, Luis
; Clofent, Joan
; Ferrandez, Ángel
; Torrealba, Leyanira
; Piñol Sánchez, Virgínia
; Rodríguez Alcalde, Daniel
; Hernández, Vicent
; Fernández Seara, Javier
|
|
|
|
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients |
Cubiella, Joaquín
; Vega, Pablo
; Salve, María
; Díaz Ondina, Marta
; Alves, Maria Teresa
; Quintero, Enrique
; Álvarez Sánchez, Victoria
; Fernández Bañares, Fernándo
; Boadas, Jaume
; Campo, Rafel
; Bujanda, Luis
; Clofent, Joan
; Ferrandez, Ángel
; Torrealba, Leyanira
; Piñol Sánchez, Virgínia
; Rodríguez Alcalde, Daniel
; Hernández, Vicent
; Fernández Seara, Javier
|
|
|
2018 June 1 |
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients |
|
|
|
2018 June 5 |
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients |
Cubiella, Joaquín
; Vega, Pablo
; Salve, María
; Díaz Ondina, Marta
; Alves, Maria Teresa
; Quintero, Enrique
; Álvarez Sánchez, Victoria
; Fernández Bañares, Fernándo
; Boadas, Jaume
; Campo, Rafel
; Bujanda, Luis
; Clofent, Joan
; Ferrandez, Ángel
; Torrealba, Leyanira
; Piñol Sánchez, Virgínia
; Rodríguez Alcalde, Daniel
; Hernández, Vicent
; Fernández Seara, Javier
|
|
|
|
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez Martín, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufí González, Sílvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez Martínez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
|
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez Martín, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufí González, Sílvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez Martínez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
2018 June 1 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
|
|
|
2018 June 5 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez Martín, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufí González, Sílvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez Martínez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
2011 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez Martín, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Maria Rosa
; Cufí González, Sílvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez Martínez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
|
Intestinal microbiota in the adenoma progression to colorectal cancer: a cross-sectional study |
Brujats Rubirola, Anna
|
|
|
2014 November |
Intestinal microbiota in the adenoma progression to colorectal cancer: a cross-sectional study |
Brujats Rubirola, Anna
|
|
|
|
Intestinal microbiota in the adenoma progression to colorectal cancer: a cross-sectional study |
Brujats Rubirola, Anna
|
|
|
2016 September 12 |
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
|
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
|
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
2018 June 1 |
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
|
|
|
2018 June 5 |
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
2012 |
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez Martín, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufí González, Sílvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
|
|
|
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez Martín, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufí González, Sílvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
|
|
|
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez Martín, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufí González, Sílvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
|
|
2018 June 1 |
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
|
|
|
2018 June 5 |
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
Oliveras Ferrarós, Cristina
; Massaguer i Vall-llovera, Anna
; Vázquez Martín, Alejandro
; Carrion Salip, Dolors
; Queralt, Bernardo
; Cufí González, Sílvia
; Martin Castillo, Begoña
; Bosch Barrera, Joaquim
; Brunet i Vidal, Joan
; Llorens Duran, Rafael de
; Menéndez Menéndez, Javier Abel
|
